Your browser doesn't support javascript.
loading
Dosimetric comparison of pencil beam scanning proton therapy with or without multi-leaf collimator versus volumetric-modulated arc therapy for treatment of malignant glioma.
Miyata, Junya; Tominaga, Yuki; Kondo, Kazuto; Sonoda, Yasuaki; Hanazawa, Hideki; Sakai, Mami; Itasaka, Satoshi; Oita, Masataka; Kuroda, Masahiro.
Afiliación
  • Miyata J; Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Okayama, Japan; Department of Radiological Technology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Tominaga Y; Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Okayama, Japan; Department of Radiotherapy, Medical Co. Hakuhokai, Osaka Proton Therapy Clinic, Osaka, Osaka, Japan.
  • Kondo K; Department of Radiological Technology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Sonoda Y; Department of Radiological Technology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Hanazawa H; Department of Radiation Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Sakai M; Department of Radiation Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Itasaka S; Department of Radiation Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Oita M; Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Okayama, Japan. Electronic address: oita-m@cc.okayama-u.ac.jp.
  • Kuroda M; Graduate School of Health Sciences, Okayama University, Okayama, Okayama, Japan.
Med Dosim ; 48(2): 105-112, 2023.
Article en En | MEDLINE | ID: mdl-36914455
ABSTRACT
This study aimed to examine the dosimetric effect of intensity-modulated proton therapy (IMPT) with a multi-leaf collimator (MLC) in treating malignant glioma. We compared the dose distribution of IMPT with or without MLC (IMPTMLC+ or IMPTMLC-, respectively) using pencil beam scanning and volumetric-modulated arc therapy (VMAT) in simultaneous integrated boost (SIB) plans for 16 patients with malignant gliomas. High- and low-risk target volumes were assessed using D2%, V90%, V95%, homogeneity index (HI), and conformity index (CI). Organs at risk (OARs) were evaluated using the average dose (Dmean) and D2%. Furthermore, the dose to the normal brain was evaluated using from V5Gy to V40Gy at 5 Gy intervals. There were no significant differences among all techniques regarding V90%, V95%, and CI for the targets. HI and D2% for IMPTMLC+ and IMPTMLC- were significantly superior to those for VMAT (p < 0.01). The Dmean and D2% of all OARs for IMPTMLC+ were equivalent or superior to those of other techniques. Regarding the normal brain, there was no significant difference in V40Gy among all techniques whereas V5Gy to V35Gy in IMPTMLC+ were significantly smaller than those in IMPTMLC- (with differences ranging from 0.45% to 4.80%, p < 0.05) and VMAT (with differences ranging from 6.85% to 57.94%, p < 0.01). IMPTMLC+ could reduce the dose to OARs, while maintaining target coverage compared to IMPTMLC- and VMAT in treating malignant glioma.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada / Terapia de Protones / Glioma Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada / Terapia de Protones / Glioma Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Japón